These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17608860)

  • 1. Experimental investigation of the role of endothelin-1 in idiopathic portal hypertension.
    Yamaguchi E; Yamanoi A; Ono T; Nagasue N
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1134-40. PubMed ID: 17608860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis.
    Nagasue N; Dhar DK; Yamanoi A; Emi Y; Udagawa J; Yamamoto A; Tachibana M; Kubota H; Kohno H; Harada T
    Hepatology; 2000 May; 31(5):1107-14. PubMed ID: 10796886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
    Biecker E; Trebicka J; Kang A; Hennenberg M; Sauerbruch T; Heller J
    Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
    Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
    Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low NaCl intake elevates renal medullary endothelin-1 and endothelin A (ETA) receptor mRNA but not the sensitivity of renal Na+ excretion to ETA receptor blockade in rats.
    Klinger F; Grimm R; Steinbach A; Tanneberger M; Kunert-Keil C; Rettig R; Grisk O
    Acta Physiol (Oxf); 2008 Mar; 192(3):429-42. PubMed ID: 17892519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAome of splenic macrophages in hypersplenism due to portal hypertension in hepatitis B virus-related cirrhosis.
    Li Z; Zhang S; Huang C; Zhang W; Hu Y; Wei B
    Exp Biol Med (Maywood); 2008 Nov; 233(11):1454-61. PubMed ID: 18791127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified canine model of portal hypertension with hypersplenism.
    Chen Y; Zhang Q; Liao Y; Guo F; Zhang Y; Zeng Q; Jin W; Shi H; Zhou M
    Scand J Gastroenterol; 2009; 44(4):478-85. PubMed ID: 19096979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.
    Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD
    Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody titers and response to vaccination against hepatitis A and B in pediatric patients with portal hypertension.
    Rosa MN; Hessel G; Alves De Tommaso AM
    Acta Gastroenterol Latinoam; 2008 Sep; 38(3):187-93. PubMed ID: 18979898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats.
    Camara PR; Ferraz GJ; Franco-Penteado CF; Sbragia-Neto L; Meirelles LR; Teixeira SA; Muscara MN; Velloso LA; Antunes E; Ferraz JG
    Eur J Pharmacol; 2008 Jul; 589(1-3):245-50. PubMed ID: 18555214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
    J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis with ketotifen in rats with portal hypertension: involvement of mast cell and eicosanoids.
    Sanchez-Patan F; Anchuelo R; Vara E; Garcia C; Saavedra Y; Vergara P; Cuellar C; Rodero M; Aller MA; Arias J
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):383-94. PubMed ID: 18693174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
    Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats.
    Matei V; Rodríguez-Vilarrupla A; Deulofeu R; García-Calderó H; Fernández M; Bosch J; Garcia-Pagán JC
    J Hepatol; 2008 Aug; 49(2):192-7. PubMed ID: 18534709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats.
    Vernerová Z; Kramer HJ; Bäcker A; Cervenka L; Opocenský M; Husková Z; Vanourková Z; Eis V; Chábová VC; Tesar V; Malý J; Vanecková I
    Vascul Pharmacol; 2008; 48(4-6):165-73. PubMed ID: 18372220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of contractile endothelin ET(B) receptors in rat coronary artery after organ culture.
    Johnsson E; Maddahi A; Wackenfors A; Edvinsson L
    Eur J Pharmacol; 2008 Mar; 582(1-3):94-101. PubMed ID: 18242601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifelong inorganic arsenic compounds consumption affected blood pressure in rats.
    Yang HT; Chou HJ; Han BC; Huang SY
    Food Chem Toxicol; 2007 Dec; 45(12):2479-87. PubMed ID: 17688991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
    Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
    J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of portal hypertension.
    Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.